|
![]() |
|||||||||||||||||||||||||||
CALL FOR ABSTRACTS Deadline for Receipt of Regular Abstracts
has been extended unitl June 10, 2005 The Parkinson Study Group (PSG), Huntington Study Group (HSG), Dystonia Study Group (DSG), Myoclonus Study Group (MSG), Tourette’s Syndrome Study Group (TSSG), Cooperative Ataxia Group (CAG), Tremor Research Group(TRG) and the Movement Disorder Society (MDS) will organize the 19th Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson’s Disease and Other Movement Disorders on Sunday, September 25, 2005, at the San Diego Marriott Hotel and Marina, San Diego, California, immediately preceding the meeting of the American Neurological Association. This peer-reviewed program will include both platform and poster presentations. Abstracts will be published in the September issue of Movement Disorders and must not have been published or presented prior to the Symposia. Authors will be asked to disclose relationships with funding sources and manufacturers of commercial products discussed in the presentation. Authors need not be associated with the MDS or the study groups. There is no registration fee for attending the Symposia. Late Breaking Research Abstracts Electronic submission is required. An electronic version of this form is available by sending an e-mail request to abstract@ctcc.rochester.edu. If there are problems contact Tracy Morgan, University of Rochester (585-275-0555). ALL INFORMATION MUST BE FILLED IN BELOW ·
PLEASE TYPE Please check type of abstract: ____Regular Abstract ____Late Breaking Research Abstract
Title: Authors (list in order using following format: M.A. Rudolph, T. Morgan): Institution name, city, state/province, country of each author: Name, address, telephone, fax and e-mail of presenting author: ____Platform Preferred ____Poster Preferred (Abstract Not To Exceed 250 Word – Electronic Submission Required - Do Not Use Illustrations) Deadline for Receipt
of Regular Abstracts has been extended until June 10, 2005 |
||||||||||||||||||||||||||||
HSG Overview | Huntington's Disease Overview | What is a Clinical Trial?
|
||||||||||||||||||||||||||||